House Select Committee on China

Company

Last mentioned: Mar 19, 2026

Stories mentioning House Select Committee on China 2

regulation Bearish

US Lawmakers Sound Alarm Over Chinese Dominance in Pharmaceutical Supply Chain

The House Select Committee on China has warned that Beijing is executing a strategic 'playbook' to dominate the global pharmaceutical market, mirroring its previous successes in rare earths and electric vehicles. With Chinese medical revenue projected to reach $2.1 trillion by 2030, US officials are weighing the national security risks of a supply chain heavily dependent on Chinese-made active pharmaceutical ingredients.

3 sources
regulation Bearish

US Lawmakers Sound Alarm Over China’s Growing Dominance in Pharma Supply Chain

A high-profile House Select Committee hearing has highlighted the United States' critical dependence on Chinese active pharmaceutical ingredients (APIs). Lawmakers warn that Beijing is applying its successful industrial playbook from rare earths and EVs to corner the global medicine market, with Chinese pharma revenue projected to hit $2.1 trillion by 2030.

3 sources